As the ISICEM comes to a close, we would like to thank everyone who took the time to connect with us.

It was a pleasure to engage with so many dedicated professionals. We are encouraged by the strong interest in Efferon technologies, and in particular, the remarkable attention around EfferonNEO.

We believe that next-generation extracorporeal therapies play a key role in critical care. At Efferon, we are committed not only to technological innovation but also to robust scientific validation.

The effectiveness of Efferon NEO is supported by a large, multicenter clinical trial, reflecting our commitment to generating high-quality evidence.

We look forward to sharing more updates and results with you very soon.

Thank you again, and see you at future events!